Skip to main content

UBS Group AG

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in CAPR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,921,435
+$3,613,122 QoQ
Shares Held
619,661
+66.6% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 169 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,173,307 across 562 Biotechnology names. CAPR ranks #95 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CAPR

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,921,435 619,661
2026-03-31 $11,308,313 371,984
2025-12-31 $6,874,912 238,216
2025-09-30 $899,209 124,717
2025-06-30 $5,455,809 549,427
2025-03-31 $3,732,824 393,343
2024-12-31 $1,694,888 122,818
2024-09-30 $199,524 13,118
2024-06-30 $41,436 8,687
2024-03-31 $10,185 1,500
2023-03-31 $18,732 4,439
2022-06-30 $102,438 29,352
2022-03-31 $23,632 6,890
2021-12-31 $10,981 3,748
2021-06-30 $9,859 1,922
2021-03-31 $1,755 375
2020-12-31 $17,410 5,076
2020-09-30 $9,975 1,900
2020-06-30 $4,600 1,000
2020-03-31 $1,726 1,439